ESPR,Esperion Therapeutics, Inc. | Healthcare

Healthcare

ESPR

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Esperion Therapeutics, Inc.ESPR

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol.

Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia.

The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program.

Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Latest News >

Samsung's Q3 profit misses estimates as it struggles in AI chips

Oct 7, 2024

SEOUL, Oct 8 (Reuters) - Samsung Electronics ( SSNLF ) estimated on Tuesday its third-quarter operating profit jumped 274%, but that was short of analysts' estimates as the tech giant struggled to capitalise on strong demand for chips used in artificial intelligence servers. The world's largest memory chip, smartphone and TV maker estimated an operating profit of 9.1 trillion won...

PRECIOUS-Gold flat as markets await Fed minutes

Oct 7, 2024

Oct 8 (Reuters) - Gold prices were flat in early Asian hours on Tuesday as market participants awaited minutes of the U.S. Federal Reserve's last meeting and more economic data for further clarity on policy easing this year. FUNDAMENTALS * Spot gold was little changed at $2,643.68 per ounce, as of 0013 GMT. U.S. gold futures fell 0.1% to $2,662.90....

Japan's Nikkei falls after Wall Street's weak finish

Oct 7, 2024

TOKYO, Oct 8 (Reuters) - Japan's Nikkei share average retreated on Tuesday, weighed down by Wall Street's weak finish overnight and rising U.S. yields on reduced bets of another large rate cut following Friday's strong jobs report. The Nikkei was down 0.8% at 39,016.79, as of 0008 GMT, after closing 1.8% higher on Monday. The broader Topix was down 0.98%...

Cannae, KDSA to Buy Majority Stake in The Watkins Company

Oct 7, 2024

04:59 PM EDT, 10/07/2024 (MT Newswires) -- Cannae Holdings ( CNNE ) and KDSA Investment Partners said Monday they have agreed to buy a majority stake in The Watkins Company, a flavoring products company. The current majority owner and Chairman, Mark Jacobs, will roll a significant equity stake into the transaction, the companies said. They expect to close the deal...